logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

MIKO INTL (01247) issued 800,000 shares due to a non-director exercising their subscription rights.

date
18/09/2025
avatar
GMT Eight
Mig International Holdings (01247) announced that on September 18, 2025, a non-executive director of the company exercised stock options according to the stock option plan.
MIKO INTL (01247) announces that on September 18, 2025, it issued 800,000 shares at an issue price of HK$1.07 per share due to the exercise of share options by non-directors under the share option scheme.
Related Articles
US Stock Market Move | Intel Corporation (INTC.US) surges more than 25% with a $5 billion investment from NVIDIA Corporation.
HK Stock
SILKWAVE INC (00471) completed the issuance of 19,063,900 subscription shares.
US Stock
Biogen (BIIB.US) plans to acquire Alcyone to expand drug delivery solutions.
US Stock Market Move | Intel Corporation (INTC.US) surges more than 25% with a $5 billion investment from NVIDIA Corporation.
SILKWAVE INC (00471) completed the issuance of 19,063,900 subscription shares.
HK Stock
Biogen (BIIB.US) plans to acquire Alcyone to expand drug delivery solutions.
US Stock
RECOMMEND
Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
icon
18/09/2025
Why Generating Profit Remains Challenging for Lidar Companies
Why Generating Profit Remains Challenging for Lidar Companies
icon
18/09/2025
SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
icon
18/09/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.